Literature DB >> 17765382

A 90-day subchronic toxicity study of nivalenol, a trichothecene mycotoxin, in F344 rats.

Miwa Takahashi1, Makoto Shibutani, Yoshiko Sugita-Konishi, Maki Aihara, Kaoru Inoue, Gye-Hyeong Woo, Hitoshi Fujimoto, Masao Hirose.   

Abstract

A subchronic toxicity study of nivalenol (NIV), a trichothecene mycotoxin, was conducted in male and female F344 rats fed diet containing 0, 6.25, 25 or 100 ppm concentration for 90 days. Decrease of body weight and loose stools were observed at 100 ppm in both sexes from the start of the experiment, and body weight reduction was also observed at 25 ppm in males from week 6. At necropsy, many organs demonstrated reduced absolute weights at 100 ppm in both sexes, mostly due to the reduction in the body growth, with reduction of relative thymus weight also being evident in females. Hematologically, decrease of the white blood cell count was found at 100 ppm in males and from 6.25 ppm in females. In addition, decreased platelet counts in both sexes, red blood cell counts in males, and the hemoglobin concentration in females were detected at 100 ppm. Histopathologically, treatment-related changes were predominantly observed in the hematopoietic and immune organs and the anterior pituitary in both sexes and female reproductive organs at 100 ppm, such as thymic atrophy, hypocellularity in the bone marrow, diffuse hypertrophy of basophilic cells with increase of castration cells in the anterior pituitary, and increase of ovarian atretic follicles. Based on the hematological data, the no-observed-adverse-effect level of NIV was determined to be less than 6.25 ppm (0.4 mg/kg body weight/day for both males and females).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765382     DOI: 10.1016/j.fct.2007.07.005

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  7 in total

1.  Bacterial cytochrome P450 system catabolizing the Fusarium toxin deoxynivalenol.

Authors:  Michihiro Ito; Ikuo Sato; Masumi Ishizaka; Shin-ichiro Yoshida; Motoo Koitabashi; Shigenobu Yoshida; Seiya Tsushima
Journal:  Appl Environ Microbiol       Date:  2012-12-28       Impact factor: 4.792

2.  Combined Exposure to Multiple Mycotoxins: An Example of Using a Tiered Approach in a Mixture Risk Assessment.

Authors:  Annick D van den Brand; Bas G H Bokkers; Jan Dirk Te Biesebeek; Marcel J B Mengelers
Journal:  Toxins (Basel)       Date:  2022-04-26       Impact factor: 5.075

3.  The Kidneys of Infant Mice are not Sensitive to the Food Mycotoxin Contaminant Nivalenol.

Authors:  Kaoru Inoue; Miwa Takahashi; Yukio Kodama; Akiyoshi Nishikawa; Yoshiko Sugita-Konishi; Midori Yoshida
Journal:  J Toxicol Pathol       Date:  2014-04-30       Impact factor: 1.628

4.  Spike culture derived wheat (Triticum aestivum L.) variants exhibit improved resistance to multiple chemotypes of Fusarium graminearum.

Authors:  Chen Huang; Manu P Gangola; Seedhabadee Ganeshan; Pierre Hucl; H Randy Kutcher; Ravindra N Chibbar
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

5.  Nivalenol affects Cyclin B1 level and activates SAC for cell cycle progression in mouse oocyte meiosis.

Authors:  Ping-Shuang Lu; Yue Wang; Le Jiao; Shao-Chen Sun
Journal:  Cell Prolif       Date:  2022-06-23       Impact factor: 8.755

6.  Protective Effect of Stachybotrys microspora Triprenyl Phenol-7on the Deposition of IgA to the Glomerular Mesangium in Nivalenol-induced IgA Nephropathy Using BALB/c Mice.

Authors:  Sayaka Kemmochi; Hitomi Hayashi; Eriko Taniai; Keiji Hasumi; Yoshiko Sugita-Konishi; Susumu Kumagai; Kunitoshi Mitsumori; Makoto Shibutani
Journal:  J Toxicol Pathol       Date:  2012-06       Impact factor: 1.628

7.  Nitric oxide mediates apoptosis and mitochondrial dysfunction and plays a role in growth hormone deficiency by nivalenol in GH3 cells.

Authors:  Deyu Huang; Luqing Cui; Pu Guo; Xijuan Xue; Qinghua Wu; Hafiz Iftikhar Hussain; Xu Wang; Zonghui Yuan
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.